TransMedics (TMDX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec10

Canaccord Genuity Analyst Maintains Buy Rating on TransMedics Group

12:07

Dec5

TransMedics Director David Weill Disposes of Company Common Stock

21:30

Dec3

William Blair Analyst Maintains Buy Rating on TransMedics Group

19:12

Nov27

TransMedics Executives Sell $435,660 in Stock

03:32

Nov26

TransMedics Group Inc. Official Disposes of Common Stock

21:31

Nov18

TransMedics CEO and President Acquires Common Stock

21:30

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 143.82 M, Net Income 24.32 M, EPS 0.6601

Jul30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 157.37 M, Net Income 34.91 M, EPS 0.9186

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 143.54 M, Net Income 25.68 M, EPS 0.7021

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More